Department of Radiation Oncology, University Medical Center Groningen, 9700 RB Groningen, The Netherlands.
Oncologist. 2011;16(3):366-77. doi: 10.1634/theoncologist.2010-0171. Epub 2011 Feb 24.
Clinical studies concerning head and neck cancer patients treated with protons reporting on radiation-induced side effects are scarce. Therefore, we reviewed the literature regarding the potential benefits of protons compared with the currently used photons in terms of lower doses to normal tissue and the potential for fewer subsequent radiation-induced side effects, with the main focus on in silico planning comparative (ISPC) studies.
A literature search was performed by two independent researchers on ISPC studies that included proton-based and photon-based irradiation techniques.
Initially, 877 papers were retrieved and 14 relevant and eligible ISPC studies were identified and included in this review. Four studies included paranasal sinus cancer cases, three included nasopharyngeal cancer cases, and seven included oropharyngeal, hypopharyngeal, and/or laryngeal cancer cases. Seven studies compared the most sophisticated photon and proton techniques: intensity-modulated photon therapy versus intensity-modulated proton therapy (IMPT). Four studies compared different proton techniques. All studies showed that protons had a lower normal tissue dose, while keeping similar or better target coverage. Two studies found that these lower doses theoretically translated into a significantly lower incidence of salivary dysfunction.
The results of ISPC studies indicate that protons have the potential for a significantly lower normal tissue dose, while keeping similar or better target coverage. Scanned IMPT probably offers the most advantage and will allow for a substantially lower probability of radiation-induced side effects. The results of these ISPC studies should be confirmed in properly designed clinical trials.
针对接受质子治疗的头颈部癌症患者的辐射诱导副作用的临床研究相对较少。因此,我们回顾了文献,比较了质子与目前使用的光子在正常组织低剂量和潜在较少的后续辐射诱导副作用方面的潜在优势,主要关注于计算机模拟规划比较(ISPC)研究。
两名独立研究人员对包括质子和光子照射技术的 ISPC 研究进行了文献检索。
最初检索到 877 篇论文,确定了 14 项相关的符合条件的 ISPC 研究,并纳入本综述。四项研究包括鼻窦癌病例,三项研究包括鼻咽癌病例,七项研究包括口咽、下咽和/或喉癌病例。七项研究比较了最先进的光子和质子技术:强度调制光子治疗与强度调制质子治疗(IMPT)。四项研究比较了不同的质子技术。所有研究表明,质子具有较低的正常组织剂量,同时保持相似或更好的靶区覆盖。两项研究发现,这些较低的剂量理论上转化为唾液功能障碍发生率显著降低。
ISPC 研究的结果表明,质子具有显著降低正常组织剂量的潜力,同时保持相似或更好的靶区覆盖。扫描 IMPT 可能提供最大的优势,并允许显著降低辐射诱导副作用的概率。这些 ISPC 研究的结果应在适当设计的临床试验中得到证实。